Shanghai Sui’an Biotechnology secures multi-million-yuan angel round

Shanghai Sui’an Biotechnology has received millions of yuan in an angel round of financing from individual investors.
Sui’an Biotechnology was established in April 2019, and its CTC detection nanotechnology began to be developed as early as 2012, and it took shape in the laboratory in 2016.

Shanghai Sui’an Biotechnology has received millions of yuan in an angel round of financing from individual investors.

Sui’an Biotechnology was established in April 2019, and its CTC detection nanotechnology began to be developed as early as 2012, and it took shape in the laboratory in 2016.

Because it has developed a unique circulating tumor cell (CTC) detection nanotechnology, using the special metabolic characteristics of cancer cells, and the resulting special biophysical characteristics, it achieves the broad spectrum, high efficiency, high sensitivity and high specificity which solves the bottleneck problem that has long restricted the development of the CTC industry.

The founder, Dr. Chen Bingdi, introduced that Sui’an Biotechnology adopted a completely different and innovative approach-the application of the difference between tumor cells and normal cells in glucose metabolism for CTC capture. Compared with the existing separation technology, separation in this way can achieve higher capture efficiency, high sensitivity and high specificity.

At present, Sui’an Biotechnology is mainly focused on CTC technical services. After the completion of the development of automatic instruments in the future, it will provide integrated “reagent + instrument” products to the market.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/04/shanghai-sui-an-biotechnology-secures-multi-million-yuan-angel-round/.

Leave a Reply

Please Login to Comment